Galectin Therapeutics | GALT - EPS Earnings Per Share

Stock Price
3.02
Daily Change
0.05 1.68%
Monthly
-3.21%
Yearly
106.85%
Q1 Forecast
2.88

Galectin Therapeutics reported $-0.2 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Galectin Therapeutics USD -0.2 0.01 Jun/2024
Gilead Sciences USD 1.86 0.61 Dec/2025
Immunic USD -0.24 0.03 Sep/2024
Incyte USD 1.8 0.46 Dec/2025
Merck USD 2.04 0.54 Dec/2025